Literature DB >> 12653714

Fish odour syndrome with features of both primary and secondary trimethylaminuria.

E A Fraser-Andrews1, N J Manning, G H S Ashton, P Eldridge, J McGrath, H du P Menagé.   

Abstract

We report a patient with the fish odour syndrome who has both primary and secondary trimethylaminuria. The diagnosis was made using biochemical and genetic analysis in the apparent absence of any characteristic smell. Differentiation of primary and secondary trimethylaminuria is usually made on urinary analysis of trimethylamine and its metabolite trimethylamine N-oxide, with different, characteristic patterns of both compounds in primary and secondary trimethylaminuria. Our patient had biochemical analysis consistent with a diagnosis of secondary trimethylaminuria, while analysis of the flavin-containing mono-oxygenase 3 gene, the causative gene in primary trimethylaminuria, demonstrated three sequence polymorphisms, two of which are known to reduce enzyme activity. The patient showed temporary clinical and biochemical response to treatment with metronidazole and neomycin. It is important to be aware of this diagnosis in patients without obvious clinical signs, and of the subjective benefits of treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653714     DOI: 10.1046/j.1365-2230.2003.01230.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Clinical utility gene card for: trimethylaminuria.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

2.  Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy.

Authors:  Nigel J Manning; Elizabeth K Allen; Richard J Kirk; Mark J Sharrard; Edwin J Smith
Journal:  JIMD Rep       Date:  2011-11-20

3.  Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae.

Authors:  Gints Kalnins; Janis Kuka; Solveiga Grinberga; Marina Makrecka-Kuka; Edgars Liepinsh; Maija Dambrova; Kaspars Tars
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

4.  Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.

Authors:  R A Chalmers; M D Bain; H Michelakakis; J Zschocke; R A Iles
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 5.  A review of trimethylaminuria: (fish odor syndrome).

Authors:  Jeffrey Messenger; Shane Clark; Susan Massick; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

6.  Clinical utility gene card for: Trimethylaminuria - update 2014.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

7.  Gut-Brain Axis Cross-Talk and Limbic Disorders as Biological Basis of Secondary TMAU.

Authors:  Luigi Donato; Simona Alibrandi; Concetta Scimone; Andrea Castagnetti; Giacomo Rao; Antonina Sidoti; Rosalia D'Angelo
Journal:  J Pers Med       Date:  2021-01-31

Review 8.  The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad.

Authors:  Emily S Krueger; Trevor S Lloyd; Jeffery S Tessem
Journal:  Nutrients       Date:  2021-08-21       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.